The decellularized porcine heart valve matrix in tissue engineering: Platelet adhesion and activation

Thrombosis and Haemostasis

Volumn 94, Issue 3, 2005, Pages 562-567

  Kasimir, Marie Theres ^a   Weigel, Guenter ^a   Sharma, Jyotindra ^a   Rieder, Erwin ^a   Seebacher, Gernot ^a   Wolner, Ernst ^a   Simon, Paul ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Biotechnology; Decellularized porcine matrix; Heart valves; Thrombogenicity; Tissue engineering

Indexed keywords

DEOXYCHOLATE SODIUM; FIBRINOGEN RECEPTOR; GLUTARALDEHYDE; NONOXINOL 9; RIBONUCLEASE; TRITON X 100;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; ENZYME DEGRADATION; EXTRACELLULAR MATRIX; FLUORESCENT ANTIBODY TECHNIQUE; FROZEN SECTION; HEART VALVE PROSTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LASER MICROSCOPE; LASER MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCANNING ELECTRON MICROSCOPE; SCANNING ELECTRON MICROSCOPY; SWINE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE RICH PLASMA; THROMBOGENICITY; TISSUE ENGINEERING; TISSUE FIXATION; UMBILICAL VEIN;

ANIMALS; AORTIC VALVE; BIOPROSTHESIS; BLOOD PLATELETS; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HUMANS; PLATELET ACTIVATION; PLATELET ADHESIVENESS; SURFACE-ACTIVE AGENTS; SWINE; THROMBOSIS; TIME FACTORS; TISSUE ENGINEERING;

EID: 24044481865     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH05-01-0025     Document Type: Article

References (46)

1. Massberg S, Brand K, Grüner S et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002; 196: 887-96.
2. Mustard JF, Packham MA, Kinlough-Rathbone RL. Platelets, blood flow and the vessel wall. Circulation 1990; 81(1 Suppl): I24-7.
3. Cannegieter SC, Rosendaal FR, Wintzen AR et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11-7.
4. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994; 89: 635-41.
5. Jackson MR, Johnson WC, Williford WO et al. The effect of anticoagulation and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial. J Vasc Surg 2002; 35: 292-8.
6. Sodian R, Hoerstrup SP, Jason S et al. Tissue engineering of heart valves: In vitro experiences. Ann Thorac Surg 2000; 70: 140-4.
7. Sodian R, Hoerstrup SP, Jason S, et al. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation 2000; 102: (19 Suppl 3): III22-9.
8. Hoerstrup SP, Zund G, Cheng S et al. A new approach to completely autologous cardiovascular tissue in humans. ASAIO J 2002; 48: 234-8.
9. Quing Y, Zünd G, Benedikt P et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2000; 17: 587-91.
10. Jockenhoevel S, Zund G, Hoerstrup SP et al. Fibrin gel-advantages of a new scaffold in cardiovascular tissue engineering. Eur J Cardiothorac Surg 2001; 19: 424-30.
11. Kim WG, Park JK, Park YN et al. Tissue-engineered heart valve leaflets: an effective method for seeding autologous cells on scaffold. Int J Artif Organs 2000; 23: 624-8.
12. Teebken OE, Bader A, Steinhoff G et al. Tissue engineering of vascular grafts: Human cell seeding of decellularized porcine matrix. Eur J Vasc Endovasc Surg 2000; 19: 381-6.
13. Bader A, Schilling T, Teebken OE et al. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg 1998; 14: 279-84.
14. O'Brian MF, Goldstein S, Walsh SP et al. The Synergraft valve: A new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization; first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg 1999; 11 (Suppl 1): 194-200.
15. Goldstein S, Clarke DR, Walsh SP et al. Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann Thorac Surg 2000; 70: 1962-9.
16. Da Costa A, Dohmen PM, Lopes SV. Comparison of cryopreserved homografts and decellularized porcine heterografts implanted in sheep. Artif Organs 2004; 28: 366-70.
17. Kasimir MT, Rieder E, Seebacher G et al. Comparison of different decellularization procedures of porcine heart valves. Int J Artif Organs 2003; 26: 421-7.
18. Rieder E, Kasimir MT, Silberhumer G et al. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004; 127: 399-405.
19. Weigel G, Bertalanffy P, Wolner E. Depletion of intracellular GTP results in nuclear factor-κB activation and intercellular adhesion molecule-1 expression in human endothelial cells. Mol Pharmacol 2002; 62: 453-62.
20. Amiji M, Park H, Park K. Study on the prevention of surface induced platelet activation by albumin coating. J Biomater Sci Polymer 1992; 3: 375-88.
21. Ginsberg MH, Frelinger AL, Lam S et al. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood 1990; 76: 2017-23.
22. Bennett JS, Shattil SJ, Power JW et al. Interaction of fibrinogen with its platelet receptor. J Biol Chem 1988; 263: 12948-53.
23. Shattil SJ, Hoxie JA, Cunningham M et al. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-14.
24. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials 2004; 25: 5681-703.
25. Simon P, Kasimir MT, Seebacher G et al. Early failure of the tissue engineered porcine heart valve Synergraft™ in paediatric patients. Eur J Cardiothorac Surg 2003; 23: 1002-6.
26. Fann JI, Miller DC, Moore KA et al. Twenty-year clinical experience with porcine bioprosthesis. Ann Thorac Surg 1996; 62: 1301-11.
27. Cohn LH, Collins JJ Jr, DiSesa VJ et al. Fifteen-year experience with 1678 Hancock porcine bioprosthetic heart valve replacements. Ann Thorac Surg 1989; 210: 435-42.
28. Grunkemeier GL, Jamieson WR, Miller DC et al. Actuarial versus actual risk of porcine structural valve deterioration. J Thorac Cardiovasc Surg 1994; 108: 709-18.
29. Koolbergen DR, Hazekamp MG, de Heer E et al. Structural degeneration of pulmonary homografts used as aortic valve substitute underlines early graft failure. Eur J Cardiothorac Surg 2002; 22: 802-7.
30. Grabenwoger M, Sider J, Fitzal F et al. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material. Ann Thorac Surg 1996; 62: 772-7.
31. Girardot MN, Torrianni M, Dillehay D et al. Role of glutaraldehyde in calcification of porcine heart valves: comparing cusp and wall. J Biomed Mater Res 1995; 29: 793-801.
32. Thrubikar MJ, Deck JD, Aouad J et al. Role of mechanical stress in calcification of aortic bioprosthetic valves. J Thorac Cardiovasc Surg 1983; 86, 115-25.
33. Wagner DD, Burger P. Platelet in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-7.
34. Levy M, van der Poll T, Büller HR. Bidirectional relation between inflammation and coagulation. Circulation 2004; 109: 2698-704.
35. Rieder E, Kasimir MT, Seebacher G et al. Tissue engineering of heart valves decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005; 111: 2792-7.
36. Kuiper PH, Gallardo Torres HI, van der Linden JA et al. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 1996; 87: 3271-81.
37. Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9: 61-7.
38. Von Hundelshausen P, Weber KS, Huo Y et al. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001; 103: 1772-7.
39. Massberg S, Vogt F, Dickfeld T et al. Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thromb Res 2003; 110: 187-94.
40. Osborn L. Leukocyte adhesion to endothelium in inflammation. Cell 1990; 62: 3-6.
41. Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB 1992; 6: 2591-9.
42. Herring MB, Compton R, Legrand DR et al. Endothelial cell seeding in the management of vascular thrombosis. Semin Thromb Haemost 1989; 5: 200-5.
43. Schenke-Layland K, Opitz F, Gross M et al. Complete dynamic repopulation of decellularized heart valves by application of defined physical signs - an in vitro study. Cardiovasc Res 2003; 60: 497-509.
44. Jamieson WR, Ling H, Burr LH et al. Carpentier Edwards supraannular porcine bioprosthesis evaluation over 15 years. Ann Thorac Surg 1998; 66: S49-52.
45. Jensen N, Lindblad B, Ljungberg J et al. Early attachement of platelets, leukocytes and fibrinogen in endothelial cell seeded Dacron grafts. Ann Vasc Surg 1996; 10: 530-6.
46. Ortenwall P, Wadenvik H, Kutti J et al. Endothelial cell seeding reduces thrombogenicity of Dacron grafts in humans. J Vasc Surg 1990; 11: 403-10.